Pharma in China, untapped markets and drug development - European Medical Journal

Pharma in China, untapped markets and drug development

General Healthcare

GOLD Podcast | Season 2: Episode 07

In this episode, GOLD is joined by Isabel Afonso, General Manager, Novartis Oncology China, who shares insights on the pharmaceutical landscape of the country and the potential of partnerships with multinational corporations, followed by a conversation with Dr Farid Khan, CEO and Founder, PharmaKure, about the vital ongoing need for drug development and the scientific details behind biopharmaceuticals.

Spotify | Apple | Acast | Amazon Music

Download MP3 (mp3, 32:07 mins)


Click here to subscribe to the weekly newsletter for more insights from GOLD.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now